CD4 and pulmonary arterial hypertension: For instance, a 100 ng/m3 incremental increase in PAH exposure during month eight was associated with reduction of CD3+ cells by 2.6% (95% CI: 1.2, 3.9) and CD4+ cells by 1.8% (95% CI: 0.6, 2.9).